• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 3. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 4. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 5. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylbutylamines

Introduction to N-(2-hydroxy-2-methyl-4-phenylbutyl)-4-(trifluoromethoxy)benzene-1-sulfonamide (CAS No. 1351582-82-5)

N-(2-hydroxy-2-methyl-4-phenylbutyl)-4-(trifluoromethoxy)benzene-1-sulfonamide, identified by its CAS number 1351582-82-5, is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry. This compound belongs to a class of sulfonamides, which are well-known for their diverse biological activities and therapeutic potential. The structural features of this molecule, particularly the presence of a trifluoromethoxy group and a 2-hydroxy-2-methyl-4-phenylbutyl side chain, contribute to its unique chemical properties and make it a promising candidate for further investigation in drug discovery and development.

The sulfonamide functional group (-SO₂NH₂) is a key pharmacophore in many drugs, exhibiting a wide range of biological activities including antimicrobial, anti-inflammatory, and antiviral properties. The introduction of the trifluoromethoxy group into the benzene ring enhances the lipophilicity and metabolic stability of the molecule, which can be crucial for its absorption, distribution, metabolism, and excretion (ADME) profiles. Additionally, the 2-hydroxy-2-methyl-4-phenylbutyl side chain adds complexity to the molecule, potentially influencing its binding affinity to biological targets and overall pharmacological activity.

In recent years, there has been a growing interest in the development of novel sulfonamides as therapeutic agents due to their favorable pharmacokinetic properties and low toxicity. Research has shown that sulfonamides can interact with various biological targets, including enzymes and receptors, leading to modulation of cellular processes. For instance, studies have demonstrated that sulfonamides can inhibit bacterial growth by interfering with folic acid synthesis in pathogens. This mechanism has been exploited in the development of antibiotics like sulfamethoxazole.

The compound N-(2-hydroxy-2-methyl-4-phenylbutyl)-4-(trifluoromethoxy)benzene-1-sulfonamide represents an innovative approach in the design of sulfonamide derivatives. The combination of the trifluoromethoxy group and the bulky 2-hydroxy-2-methyl-4-phenylbutyl side chain suggests potential applications in areas such as oncology, where sulfonamides have shown promise as inhibitors of tyrosine kinases and other enzymes involved in cancer cell proliferation. Furthermore, the presence of both hydroxyl and methyl groups in the side chain may enhance solubility and bioavailability, making it more suitable for oral administration.

The synthesis of N-(2-hydroxy-2-methyl-4-phenylbutyl)-4-(trifluoromethoxy)benzene-1-sulfonamide involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Techniques such as nucleophilic substitution reactions and protecting group strategies are commonly employed in its synthesis. Advanced spectroscopic methods like nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) are utilized to confirm the structural integrity of the compound at each synthetic step.

Evaluation of the pharmacological properties of this compound is crucial for determining its potential therapeutic applications. In vitro studies using cell culture models have been instrumental in assessing its cytotoxicity, genotoxicity, and ability to modulate specific biological pathways. Additionally, preclinical studies involving animal models provide insights into its pharmacokinetic behavior and safety profile. These studies are essential for identifying any potential adverse effects before moving into human clinical trials.

The role of computational chemistry in drug discovery cannot be overstated. Molecular modeling techniques are employed to predict how N-(2-hydroxy-2-methyl-4-phenylbutyl)-4-(trifluoromethoxy)benzene-1-sulfonamide interacts with biological targets at the molecular level. These predictions help guide experimental design by identifying key interactions that may contribute to its therapeutic efficacy. Furthermore, virtual screening algorithms can be used to identify potential binding sites on target proteins, providing a rational basis for structure-based drug design.

The impact of this compound on future drug development is significant. As sulfonamides continue to be explored as lead compounds for new therapies, derivatives like N-(2-hydroxy-2-methyl-4-phenylbutyl)-4-(trifluoromethoxy)benzene-1-sulfonamide offer new possibilities for addressing unmet medical needs. Its unique structural features make it a versatile scaffold for further modifications aimed at optimizing its pharmacological properties. Collaborative efforts between synthetic chemists, biologists, and pharmacologists are essential for translating these findings into tangible therapeutic benefits.

In conclusion, N-(2-hydroxy-2-methyl-4-phenylbutyl)-4-(trifluoromethoxy)benzene-1-sulfonamide (CAS No. 1351582-82-5) is a promising compound with significant potential in pharmaceutical research. Its complex structure and unique functional groups make it an attractive candidate for further investigation into various therapeutic applications. As our understanding of molecular interactions continues to evolve, compounds like this will play a crucial role in shaping the future of drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)